Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021)
Pharma-Bio Serv (PBSV) posted Short term Debt of $1.3 million for Q2 2021, little changed on a QoQ basis from $1.3 million in Q1 2021, and up 100.0% year-over-year from $643900.0 in Q2 2020.
Pharma-Bio Serv (PBSV) Short term Debt (2020 - 2021) Analysis & Trends
Pharma-Bio Serv's Short term Debt history runs 2 years deep, the most recent figure standing at $1.3 million for Q2 2021.
- Quarterly Short term Debt rose 100.0% year-over-year to $1.3 million in Q2 2021, while the trailing twelve-month figure through Apr 2021 was $1.3 million (up 100.0% YoY) and the FY2020 annual result came in at $1.3 million, changed N/A from the prior year.
- Short term Debt was $1.3 million for Q2 2021 at Pharma-Bio Serv, roughly flat from $1.3 million in the prior quarter.
- Across five years, Short term Debt topped out at $1.3 million in Q4 2020 and bottomed at $643900.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2021 | 1.29 Mn |
| Jan 31, 2021 | 1.29 Mn |
| Oct 31, 2020 | 1.29 Mn |
| Jul 31, 2020 | 965,850.00 |
| Apr 30, 2020 | 643,900.00 |